Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Cardiopulmonary resuscitation (CPR) complications encountered in forensic autopsy cases..
BMC Emerg Med. 19(1), 23.
(2019). Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?.
Angiology. 60(1), 74-81.
(2009). Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes..
J Diabetes Complications. 23(3), 160-6.
(2009). Cardiothoracic diseases: basic treatment..
J Thorac Dis. 6 Suppl 1, S1.
(2014). Cardiovascular benefits of bariatric surgery in morbidly obese patients..
Obes Rev. 12(7), 515-24.
(2011). Cardiovascular complications in patients with Turner's syndrome..
Curr Pharm Des.
(2020). Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes..
Nat Rev Nephrol. 11(2), 70-2.
(2015). Cardiovascular effects of dipeptidyl peptidase-4 inhibitors..
Hippokratia. 19(3), 195-9.
(2015). Cardiovascular Emergencies..
Biomed Res Int. 2017, 7210261.
(2017). Cardiovascular magnetic resonance: a powerful diagnostic and prognostic tool in modern cardiology..
Prog Cardiovasc Dis. 54(3), 179-80.
(2011).
(2020). Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients..
Hellenic J Cardiol. 60(1), 28-35.
(2019). Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases..
Int J Cardiol. 236, 151-156.
(2017). Cardiovascular magnetic resonance in heart failure..
Curr Cardiol Rep. 13(3), 210-9.
(2011). Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015). Cardiovascular risk assessment in elderly individuals without overt CVD disease. Could traditional risk factors fit in all ages?.
J Clin Hypertens (Greenwich). 21(8), 1153-1154.
(2019). Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome..
Angiology. 61(1), 49-57.
(2010). Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update..
J Clin Endocrinol Metab. 99(1), 18-29.
(2014). Cardiovascular Risk in Middle East Populations: A Call to Action..
Angiology. 66(9), 801-2.
(2015). Cardiovascular risk in psoriatic arthritis: should we focus on hypertension and diabetes only?.
Clin Exp Rheumatol. 32(6), 995.
(2014). Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps..
Ther Adv Musculoskelet Dis. 8(3), 86-101.
(2016). Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?.
J Nucl Cardiol.
(2018). Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients..
Curr Med Res Opin. 29(7), 791-2.
(2013). Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.
Therapeutic Advances in Drug Safety. 7(2), 36 - 38.
(2016). Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications..
Ther Adv Drug Saf. 7(2), 36-8.
(2016).